Market Place
Sourcing Support
Jasper Therapeutics Reports 2025 Financials & Corporate Update
30 Mar 2026 //
GLOBENEWSWIRE
Jasper Therapeutics To Present At TD Cowen Healthcare Conference
24 Feb 2026 //
GLOBENEWSWIRE
Jasper Therapeutics: Positive Briquilimab Data in CSU Urticaria
08 Jan 2026 //
GLOBENEWSWIRE
Jasper Therapeutics Names Jeet Mahal CEO to Lead Clinical Growth
07 Jan 2026 //
GLOBENEWSWIRE
Jasper Therapeutics Reveals Briquilimab Asthma Study Data
02 Dec 2025 //
GLOBENEWSWIRE
Jasper Therapeutics Hosts Investor Webinar On Asthma Study Data
01 Dec 2025 //
GLOBENEWSWIRE
Jasper Therapeutics Unveils Q3 2025 Financials & Corporate Update
10 Nov 2025 //
GLOBENEWSWIRE
Jasper Therapeutics To Present At Upcoming Investor Conferences
04 Nov 2025 //
GLOBENEWSWIRE
Jasper Therapeutics Price $30M Public Offering of Stock, Warrants
19 Sep 2025 //
GLOBENEWSWIRE
Jasper Pharma Proposes Public Offering of Stock and Warrants
18 Sep 2025 //
GLOBENEWSWIRE
Jasper Therapeutics to Present at Upcoming Investor Conferences
27 Aug 2025 //
GLOBENEWSWIRE
Jasper Therapeutic Reorganizes & Cut Costs to Extend Cash Runway
09 Jul 2025 //
GLOBENEWSWIRE
Jasper`s Urticaria Study Halted by Compromised Drug Lot
08 Jul 2025 //
BIOSPACE
Jasper Warns of Restructuring After Dud Drug Derails Trials
07 Jul 2025 //
FIERCE BIOTECH
Jasper Reports Strong Data for Briquilimab in SPOTLIGHT Trial
14 Jun 2025 //
GLOBENEWSWIRE
Jasper Therapeutics to Present Briquilimab at EAACI Congress
03 Jun 2025 //
GLOBENEWSWIRE
Jasper Therapeutics to Present at Upcoming Investor Conferences
14 May 2025 //
GLOBENEWSWIRE
Jasper Therapeutics Reports Q1 2025 Financial Results and Update
12 May 2025 //
GLOBENEWSWIRE
Jasper Shares Briquilimab Data at AAAAI 2025 Meeting
01 Mar 2025 //
GLOBENEWSWIRE
Jasper To Present Late-Breaking Briquilimab Data At AAD 2025
28 Feb 2025 //
GLOBENEWSWIRE
Jasper Therapeutics to Present at March Investor Conferences
25 Feb 2025 //
GLOBENEWSWIRE
Jasper Therapeutics to Present Briquilimab at AAAAI Annual Meeting
10 Feb 2025 //
GLOBENEWSWIRE
Jasper Therapeutics to Present at Oppenheimer Healthcare Conference
04 Feb 2025 //
GLOBENEWSWIRE
Jasper Reports Positive Briquilimab Data For Chronic Urticaria
08 Jan 2025 //
GLOBENEWSWIRE
Jasper To Present Briquilimab Data For Chronic Urticaria January 8
06 Jan 2025 //
GLOBENEWSWIRE
Jasper Doses First Patient In Briquilimab Asthma Study ETESIAN
02 Dec 2024 //
GLOBENEWSWIRE
Jasper Therapeutics to Participate at Upcoming Investor Conferences
13 Nov 2024 //
GLOBENEWSWIRE
Jasper Therapeutics Q3 2024 Financial Results & Update
07 Nov 2024 //
GLOBENEWSWIRE
Jasper Therapeutics To Present Briquilimab Data At ACAAI Meeting
24 Oct 2024 //
GLOBENEWSWIRE
Jasper Reports Data from Study of Briquilimab in Chronic Urticaria
14 Oct 2024 //
GLOBENEWSWIRE
Jasper Gets Health Canada Clearance For Briquilimab Study
10 Sep 2024 //
GLOBENEWSWIRE
Jasper Therapeutics To Present At September Investor Events
04 Sep 2024 //
GLOBENEWSWIRE
Jasper Therapeutics Reports Q2 2024 Results And Recent Developments
13 Aug 2024 //
GLOBENEWSWIRE
Jasper Presents Preclinical Briquilimab Data At EHA 2024
14 Jun 2024 //
GLOBENEWSWIRE
Jasper To Present Briquilimab Data At EAACI 2024
30 May 2024 //
GLOBENEWSWIRE
New Positive Data Presented on Briquilimab Conditioning in Fanconi Anemia
15 Mar 2024 //
GLOBENEWSWIRE
Jasper Presents Positive Final Results from Phase 1 Study of Briquilimab
10 Dec 2023 //
GLOBENEWSWIRE
Jasper Announces First Patient Dosed in Phase 1b/2a Study of Briquilimab
30 Nov 2023 //
GLOBENEWSWIRE
Jasper Announces Presentation of Positive Results from Phase 1 of Briquilimab
02 Nov 2023 //
GLOBENEWSWIRE
Jasper Appoints David Hinds as Senior Vice President, Development Operations
10 Apr 2023 //
GLOBENEWSWIRE
Jasper Announces Data from Investigator-Sponsored Study of Briquilimab
17 Feb 2023 //
GLOBENEWSWIRE
Jasper Announces Positive Data from Study of Briquilimab in Sickle Cell Disease
16 Feb 2023 //
GLOBENEWSWIRE
Jasper Announces Positive Briquilimab Data to be Presented at Tandem Meetings
13 Jan 2023 //
GLOBENEWSWIRE
Jasper Announces Development Prioritization of Briquilimab in Chronic Diseases
10 Jan 2023 //
GLOBENEWSWIRE
Jasper Announces Positive Clinical Data from a Phase I/II Trial of Briquilimab
03 Jan 2023 //
GLOBENEWSWIRE
